239 related articles for article (PubMed ID: 27874210)
41. Validity and Reliability of the 6-Item Cognitive Impairment Test for Screening Cognitive Impairment: A Review.
O'Sullivan D; O'Regan NA; Timmons S
Dement Geriatr Cogn Disord; 2016; 42(1-2):42-9. PubMed ID: 27537241
[TBL] [Abstract][Full Text] [Related]
42. What is the best dementia screening instrument for general practitioners to use?
Brodaty H; Low LF; Gibson L; Burns K
Am J Geriatr Psychiatry; 2006 May; 14(5):391-400. PubMed ID: 16670243
[TBL] [Abstract][Full Text] [Related]
43. Long-term cost-effectiveness of collaborative care (vs usual care) for people with depression and comorbid diabetes or cardiovascular disease: a Markov model informed by the COINCIDE randomised controlled trial.
Camacho EM; Ntais D; Coventry P; Bower P; Lovell K; Chew-Graham C; Baguley C; Gask L; Dickens C; Davies LM
BMJ Open; 2016 Oct; 6(10):e012514. PubMed ID: 27855101
[TBL] [Abstract][Full Text] [Related]
44. Modelling the cost-effectiveness of pay-for-performance in primary care in the UK.
Pandya A; Doran T; Zhu J; Walker S; Arntson E; Ryan AM
BMC Med; 2018 Aug; 16(1):135. PubMed ID: 30153827
[TBL] [Abstract][Full Text] [Related]
45. Implementing Assessment of Cognitive Function and Frailty Into Primary Care: Data From Frailty and Alzheimer disease prevention into Primary care (FAP) Study Pilot.
Fougère B; Oustric S; Delrieu J; Chicoulaa B; Escourrou E; Rolland Y; Nourhashémi F; Vellas B;
J Am Med Dir Assoc; 2017 Jan; 18(1):47-52. PubMed ID: 27650669
[TBL] [Abstract][Full Text] [Related]
46. Cost-effectiveness of nationwide opportunistic screening program for dementia in South Korea.
Yu SY; Lee TJ; Jang SH; Han JW; Kim TH; Kim KW
J Alzheimers Dis; 2015; 44(1):195-204. PubMed ID: 25208621
[TBL] [Abstract][Full Text] [Related]
47. Sepsis: the LightCycler SeptiFast Test MGRADE®, SepsiTest™ and IRIDICA BAC BSI assay for rapidly identifying bloodstream bacteria and fungi - a systematic review and economic evaluation.
Stevenson M; Pandor A; Martyn-St James M; Rafia R; Uttley L; Stevens J; Sanderson J; Wong R; Perkins GD; McMullan R; Dark P
Health Technol Assess; 2016 Jun; 20(46):1-246. PubMed ID: 27355222
[TBL] [Abstract][Full Text] [Related]
48. Evaluating cognitive screening instruments with the "likelihood to be diagnosed or misdiagnosed" measure.
Larner AJ
Int J Clin Pract; 2019 Feb; 73(2):e13265. PubMed ID: 30239075
[TBL] [Abstract][Full Text] [Related]
49. A Diagnostic Test Accuracy Study Investigating General Practitioner Clinical Impression and Brief Cognitive Assessments for Dementia in Primary Care, Compared to Specialized Assessment.
Creavin ST; Fish M; Lawton M; Cullum S; Bayer A; Purdy S; Ben-Shlomo Y
J Alzheimers Dis; 2023; 95(3):1189-1200. PubMed ID: 37694368
[TBL] [Abstract][Full Text] [Related]
50. A systematic review and economic evaluation of intraoperative tests [RD-100i one-step nucleic acid amplification (OSNA) system and Metasin test] for detecting sentinel lymph node metastases in breast cancer.
Huxley N; Jones-Hughes T; Coelho H; Snowsill T; Cooper C; Meng Y; Hyde C; Mújica-Mota R
Health Technol Assess; 2015 Jan; 19(2):v-xxv, 1-215. PubMed ID: 25586547
[TBL] [Abstract][Full Text] [Related]
51. Estimation of diagnostic performance of dementia screening tests: Mini-Mental State Examination, Mini-Cog, Clock Drawing test and Ascertain Dementia 8 questionnaire.
Yang L; Yan J; Jin X; Jin Y; Yu W; Xu S; Wu H; Xu Y; Liu C
Aging Ment Health; 2018 Aug; 22(8):942-946. PubMed ID: 28485630
[TBL] [Abstract][Full Text] [Related]
52. [The GPcog for detecting a population with a high risk of dementia].
Thomas P; Hazif-Thomas C; Viéban F; Faugeron P; Peix R; Clément JP
Psychol Neuropsychiatr Vieil; 2006 Mar; 4(1):69-77. PubMed ID: 16556520
[TBL] [Abstract][Full Text] [Related]
53. Validity and reliability of the Persian version of general practitioner assessment of cognition (P-GPCOG).
Rashedi V; Foroughan M; Nazari H; Seeher K; Brodaty H
Aging Ment Health; 2019 Aug; 23(8):961-965. PubMed ID: 29781711
[No Abstract] [Full Text] [Related]
54. A comparison between the Mini-Mental State Examination and Montreal Cognitive Assessment in assessing cognitive function in patients with diabetes-related dementia.
Yamakawa H; Okita M; Fukasawa R; Hatanaka H; Namioka N; Hanyu H
Psychogeriatrics; 2018 Jan; 18(1):72-73. PubMed ID: 28664625
[No Abstract] [Full Text] [Related]
55. Cost-effectiveness of a National Telemedicine Diabetic Retinopathy Screening Program in Singapore.
Nguyen HV; Tan GS; Tapp RJ; Mital S; Ting DS; Wong HT; Tan CS; Laude A; Tai ES; Tan NC; Finkelstein EA; Wong TY; Lamoureux EL
Ophthalmology; 2016 Dec; 123(12):2571-2580. PubMed ID: 27726962
[TBL] [Abstract][Full Text] [Related]
56. Cognitive screening test in primary care: cut points for low education.
Yokomizo JE; Seeher K; Oliveira GM; Silva LDSVE; Saran L; Brodaty H; Aprahamian I; Yassuda MS; Bottino CMC
Rev Saude Publica; 2018 Nov; 52():88. PubMed ID: 30484482
[TBL] [Abstract][Full Text] [Related]
57. A model-based cost-effectiveness analysis of osteoporosis screening and treatment strategy for postmenopausal Japanese women.
Yoshimura M; Moriwaki K; Noto S; Takiguchi T
Osteoporos Int; 2017 Feb; 28(2):643-652. PubMed ID: 27743068
[TBL] [Abstract][Full Text] [Related]
58. Mini-Mental State Examination: diagnostic test accuracy study in primary care referrals.
Larner AJ
Neurodegener Dis Manag; 2018 Oct; 8(5):301-305. PubMed ID: 30223710
[TBL] [Abstract][Full Text] [Related]
59. The Impact of Including Costs and Outcomes of Dementia in a Health Economic Model to Evaluate Lifestyle Interventions to Prevent Diabetes and Cardiovascular Disease.
Breeze P; Thomas C; Thokala P; Lafortune L; Brayne C; Brennan A
Med Decis Making; 2020 Oct; 40(7):912-923. PubMed ID: 32951510
[TBL] [Abstract][Full Text] [Related]
60. Cognitive screening for dementia in primary care: a systematic review.
Yokomizo JE; Simon SS; Bottino CM
Int Psychogeriatr; 2014 Nov; 26(11):1783-804. PubMed ID: 25023857
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
